A pharmaceutical composition comprising a compound of formula (1) in polymorphic crystalline Form A: ##STR00001## together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Form A (see, e.g., FIG. 6) substantially free of other polymorphic forms.